Subscribe now!
Don’t miss the most recent updates, clinical cases and scientific articles in the fields of regenerative medicine and surgery. Get the issues of BASB, the Bioteck Academy Scientific Bulletin, directly in your inbox..
Not just an ordinary newsletter, but a curated selection of our best literature.
The clinical leaflet reports the resolution of a peri-implant defect with the ultimate generation bone paste Activabone Mouldable together with the HEART pericardium membrane. Activabone Mouldable bone paste exerts its osteoconductive role through mineralized bone granules with preserved bone collagen, while its content in DBM (demineralized bone matrix) increases its regenerative potential. The size and the irregular shape of the defect require the use of a membrane with medium-long protection time and that can be fixed without the risk of breaking, such as the HEART pericardium membrane. The combination of these two devices resulted in an optimal bone regeneration.
Today we focus on a recent paper (D’Amato et al.2020), where the authors compared the clinical performances of a single injection of the Bioteck bone paste Osteoplant Activagen Injectable enriched with bone marrow concentrate (BMC), with 3 injections of methylprednisolone acetate to fill bone cysts (in femur, humerus, tibia) in 53 pediatric patients. Thanks to its unique rheology, Osteoplant Activagen Injectable bone paste can be directly injected through a trocar needle without the need of open surgery. At 2 years from the surgery, the patients were asked to complete the questionnaire “Activities Scale for Kids” (ASK). The results show the superiority of the treatment with Osteoplant Activagen + BMC (83% of success) compared to methylprednisolone acetate (59% di success).
Today we point the attention on a recent paper published on the high standing international journal The International Journal of Oral & Maxillofacial Implants (Di Stefano et al.2020), where the authors show their clinical experience with a flex cortical bone sheet (0.2 mm of thickness) in the esthetic zone. This retrospective study on 32 patients highlights, by means of CBCT analysis and Marginal Bone Loss (MBL) evaluation, the stability of the bone profiles even after 9 years from the surgery. Histological analyses at 4 months demonstrate the long barrier effect provided by the flex cortical sheet as well as its integration with the tissues and its progressive remodeling with patient’s bone.
Vicenza
Headquarter
via E. Fermi, 49
36057 Arcugnano, Vicenza (VI) - Italy
Tel. +39 0444 289366
Fax: +39 0444 285272
Torino
Multi-function production center
Via G. Agnelli, 3
10020 Riva presso Chieri, Torino (TO) - Italy
Copyright © 2024 Bioteck S.p.A. - Privacy Policy - Cookie Policy